Based on earlier pilot rat studies, a research team at UUS together with Biolink Group, has decided to start a rat study finding out more about possible effects of Biolink Groups synthetic molecules in the cardiovascular system. Of special interest in this study is possible influence by these molecules on resting heart rate and hypertension. The study is expected to be finished in Q1/Q2 of 2008.